{"meta": {"disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.", "terms": "https://open.fda.gov/terms/", "license": "https://open.fda.gov/license/", "last_updated": "2023-01-30", "results": {"skip": 0, "limit": 10, "total": 945}}, "results": [{"safetyreportversion": "3", "safetyreportid": "20298277", "primarysourcecountry": "US", "occurcountry": "US", "transmissiondateformat": "102", "transmissiondate": "20220423", "reporttype": "1", "serious": "1", "seriousnessdeath": "2", "seriousnesslifethreatening": "2", "seriousnesshospitalization": "2", "seriousnessdisabling": "2", "seriousnesscongenitalanomali": "2", "seriousnessother": "1", "receivedateformat": "102", "receivedate": "20220105", "receiptdateformat": "102", "receiptdate": "20220214", "fulfillexpeditecriteria": "1", "companynumb": "US-CELLTRION INC.-2021US017932", "duplicate": "1", "reportduplicate": [{"duplicatesource": "CELLTRION INC.", "duplicatenumb": "US-CELLTRION INC.-2021US017932"}, {"duplicatesource": "CELLTRION HEALTHCARE HUNGARY KFT", "duplicatenumb": "US-CELLTRION HEALTHCARE HUNGARY KFT-2021US017932"}], "primarysource": {"reportercountry": "US", "qualification": "5"}, "sender": {"sendertype": "2", "senderorganization": "FDA-Public Use"}, "receiver": {"receivertype": "6", "receiverorganization": "FDA"}, "patient": {"reaction": [{"reactionmeddraversionpt": "24.1", "reactionmeddrapt": "Cardiac sarcoidosis", "reactionoutcome": "6"}, {"reactionmeddraversionpt": "24.1", "reactionmeddrapt": "Off label use", "reactionoutcome": "6"}], "drug": [{"drugcharacterization": "1", "medicinalproduct": "INFLECTRA", "drugbatchnumb": "Unknown", "drugauthorizationnumb": "125544", "drugdosageform": "Powder for injection", "drugindication": "Cardiac sarcoidosis", "actiondrug": "5", "drugadditional": "3", "activesubstance": {"activesubstancename": "INFLIXIMAB-DYYB"}}]}}, {"safetyreportversion": "2", "safetyreportid": "20301818", "primarysourcecountry": "US", "occurcountry": "US", "transmissiondateformat": "102", "transmissiondate": "20220423", "reporttype": "2", "serious": "1", "seriousnessdeath": "2", "seriousnesslifethreatening": "2", "seriousnesshospitalization": "2", "seriousnessdisabling": "2", "seriousnesscongenitalanomali": "2", "seriousnessother": "1", "receivedateformat": "102", "receivedate": "20220105", "receiptdateformat": "102", "receiptdate": "20220225", "fulfillexpeditecriteria": "1", "companynumb": "US-CELLTRION INC.-2021US017975", "duplicate": "1", "reportduplicate": [{"duplicatesource": "CELLTRION INC.", "duplicatenumb": "US-CELLTRION INC.-2021US017975"}, {"duplicatesource": "CELLTRION HEALTHCARE HUNGARY KFT", "duplicatenumb": "US-CELLTRION HEALTHCARE HUNGARY KFT-2021US017975"}], "primarysource": {"reportercountry": "US", "qualification": "5"}, "sender": {"sendertype": "2", "senderorganization": "FDA-Public Use"}, "receiver": {"receivertype": "6", "receiverorganization": "FDA"}, "patient": {"reaction": [{"reactionmeddraversionpt": "24.1", "reactionmeddrapt": "Rectal haemorrhage", "reactionoutcome": "6"}, {"reactionmeddraversionpt": "24.1", "reactionmeddrapt": "Gastrointestinal sounds abnormal", "reactionoutcome": "3"}, {"reactionmeddraversionpt": "24.1", "reactionmeddrapt": "Anorectal discomfort", "reactionoutcome": "6"}, {"reactionmeddraversionpt": "24.1", "reactionmeddrapt": "Therapeutic response shortened", "reactionoutcome": "6"}], "drug": [{"drugcharacterization": "1", "medicinalproduct": "INFLECTRA", "drugbatchnumb": "Unknown", "drugauthorizationnumb": "125544", "drugdosagetext": "UNK", "drugdosageform": "Powder for injection", "drugadministrationroute": "065", "drugindication": "Product used for unknown indication", "drugenddateformat": "602", "drugenddate": "2021", "actiondrug": "1", "drugadditional": "2", "activesubstance": {"activesubstancename": "INFLIXIMAB-DYYB"}}, {"drugcharacterization": "1", "medicinalproduct": "HUMIRA", "drugbatchnumb": "Unknown", "drugstructuredosagenumb": "160", "drugstructuredosageunit": "003", "drugdosagetext": "DAY 1 (160 MG), 1X/DAY", "drugdosageform": "Solution for injection", "drugadministrationroute": "058", "drugindication": "Crohn^s disease", "drugstartdateformat": "102", "drugstartdate": "20211216", "drugenddateformat": "102", "drugenddate": "20211216", "drugtreatmentduration": "1", "drugtreatmentdurationunit": "804", "actiondrug": "5", "drugadditional": "3", "activesubstance": {"activesubstancename": "ADALIMUMAB"}}], "summary": {"narrativeincludeclinical": "CASE EVENT DATE: 20211201"}}}, {"safetyreportversion": "3", "safetyreportid": "20303473", "primarysourcecountry": "US", "occurcountry": "US", "transmissiondateformat": "102", "transmissiondate": "20220424", "reporttype": "1", "serious": "1", "seriousnessdeath": "2", "seriousnesslifethreatening": "2", "seriousnesshospitalization": "1", "seriousnessdisabling": "2", "seriousnesscongenitalanomali": "2", "seriousnessother": "1", "receivedateformat": "102", "receivedate": "20220106", "receiptdateformat": "102", "receiptdate": "20220325", "fulfillexpeditecriteria": "1", "companynumb": "US-CELLTRION INC.-2021US017899", "duplicate": "1", "reportduplicate": [{"duplicatesource": "CELLTRION INC.", "duplicatenumb": "US-CELLTRION INC.-2021US017899"}, {"duplicatesource": "CELLTRION HEALTHCARE HUNGARY KFT", "duplicatenumb": "US-CELLTRION HEALTHCARE HUNGARY KFT-2021US017899"}], "primarysource": {"reportercountry": "US", "qualification": "5"}, "sender": {"sendertype": "2", "senderorganization": "FDA-Public Use"}, "receiver": {"receivertype": "6", "receiverorganization": "FDA"}, "patient": {"reaction": [{"reactionmeddraversionpt": "24.1", "reactionmeddrapt": "Colitis ulcerative", "reactionoutcome": "6"}, {"reactionmeddraversionpt": "24.1", "reactionmeddrapt": "Anal abscess", "reactionoutcome": "6"}, {"reactionmeddraversionpt": "24.1", "reactionmeddrapt": "Drug ineffective", "reactionoutcome": "6"}], "drug": [{"drugcharacterization": "1", "medicinalproduct": "INFLECTRA", "drugbatchnumb": "Unknown", "drugauthorizationnumb": "125544", "drugstructuredosagenumb": "5", "drugstructuredosageunit": "007", "drugdosagetext": "5 MG/KG AT 0, 2, 6 WEEKS AND 8 WEEKS THEREAFER, EVERY 2 MONTHS", "drugdosageform": "Powder for injection", "drugadministrationroute": "042", "drugindication": "Colitis ulcerative", "drugstartdateformat": "610", "drugstartdate": "201910", "drugenddateformat": "610", "drugenddate": "201912", "actiondrug": "1", "activesubstance": {"activesubstancename": "INFLIXIMAB-DYYB"}}], "summary": {"narrativeincludeclinical": "CASE EVENT DATE: 20191029"}}}, {"safetyreportversion": "3", "safetyreportid": "20311528", "primarysourcecountry": "US", "occurcountry": "US", "transmissiondateformat": "102", "transmissiondate": "20220423", "reporttype": "1", "serious": "1", "seriousnessdeath": "2", "seriousnesslifethreatening": "2", "seriousnesshospitalization": "2", "seriousnessdisabling": "2", "seriousnesscongenitalanomali": "2", "seriousnessother": "1", "receivedateformat": "102", "receivedate": "20220108", "receiptdateformat": "102", "receiptdate": "20220317", "fulfillexpeditecriteria": "1", "companynumb": "US-CELLTRION INC.-2021US015924", "primarysource": {"reportercountry": "US", "qualification": "3"}, "sender": {"sendertype": "2", "senderorganization": "FDA-Public Use"}, "receiver": {"receivertype": "6", "receiverorganization": "FDA"}, "patient": {"reaction": [{"reactionmeddraversionpt": "24.1", "reactionmeddrapt": "Rheumatoid arthritis", "reactionoutcome": "6"}, {"reactionmeddraversionpt": "24.1", "reactionmeddrapt": "Loss of therapeutic response", "reactionoutcome": "6"}, {"reactionmeddraversionpt": "24.1", "reactionmeddrapt": "Overdose", "reactionoutcome": "6"}], "drug": [{"drugcharacterization": "1", "medicinalproduct": "INFLECTRA", "drugbatchnumb": "FG4226", "drugauthorizationnumb": "125544", "drugstructuredosagenumb": "900", "drugstructuredosageunit": "003", "drugdosagetext": "900MG, EVERY EIGHT WEEKS", "drugdosageform": "Powder for injection", "drugadministrationroute": "065", "drugindication": "Rheumatoid arthritis", "drugenddateformat": "102", "drugenddate": "20211116", "actiondrug": "1", "activesubstance": {"activesubstancename": "INFLIXIMAB-DYYB"}}]}}, {"safetyreportversion": "3", "safetyreportid": "20311541", "primarysourcecountry": "US", "occurcountry": "US", "transmissiondateformat": "102", "transmissiondate": "20220423", "reporttype": "1", "serious": "1", "seriousnessdeath": "1", "seriousnesslifethreatening": "2", "seriousnesshospitalization": "2", "seriousnessdisabling": "2", "seriousnesscongenitalanomali": "2", "seriousnessother": "2", "receivedateformat": "102", "receivedate": "20220108", "receiptdateformat": "102", "receiptdate": "20220225", "fulfillexpeditecriteria": "1", "companynumb": "US-CELLTRION INC.-2022US000072", "duplicate": "1", "reportduplicate": [{"duplicatesource": "CELLTRION INC.", "duplicatenumb": "US-CELLTRION INC.-2022US000072"}, {"duplicatesource": "CELLTRION HEALTHCARE HUNGARY KFT", "duplicatenumb": "US-CELLTRION HEALTHCARE HUNGARY KFT-2022US000072"}], "primarysource": {"reportercountry": "US", "qualification": "3"}, "sender": {"sendertype": "2", "senderorganization": "FDA-Public Use"}, "receiver": {"receivertype": "6", "receiverorganization": "FDA"}, "patient": {"reaction": [{"reactionmeddraversionpt": "24.1", "reactionmeddrapt": "Death", "reactionoutcome": "5"}], "drug": [{"drugcharacterization": "1", "medicinalproduct": "INFLECTRA", "drugbatchnumb": "UNKNOWN", "drugauthorizationnumb": "125544", "drugstructuredosagenumb": "400", "drugstructuredosageunit": "003", "drugdosagetext": "400 MILLIGRAM EVERY 8 WEEKS", "drugdosageform": "Powder for injection", "drugadministrationroute": "065", "drugindication": "Product used for unknown indication", "actiondrug": "5", "drugadditional": "3", "activesubstance": {"activesubstancename": "INFLIXIMAB-DYYB"}}], "summary": {"narrativeincludeclinical": "CASE EVENT DATE: 20220103"}}}, {"safetyreportversion": "2", "safetyreportid": "20316234", "primarysourcecountry": "US", "occurcountry": "US", "transmissiondateformat": "102", "transmissiondate": "20220423", "reporttype": "1", "serious": "1", "seriousnessdeath": "2", "seriousnesslifethreatening": "1", "seriousnesshospitalization": "2", "seriousnessdisabling": "2", "seriousnesscongenitalanomali": "2", "seriousnessother": "1", "receivedateformat": "102", "receivedate": "20220110", "receiptdateformat": "102", "receiptdate": "20220221", "fulfillexpeditecriteria": "1", "companynumb": "US-CELLTRION INC.-2022US000093", "duplicate": "1", "reportduplicate": [{"duplicatesource": "CELLTRION INC.", "duplicatenumb": "US-CELLTRION INC.-2022US000093"}, {"duplicatesource": "CELLTRION HEALTHCARE HUNGARY KFT", "duplicatenumb": "US-CELLTRION HEALTHCARE HUNGARY KFT-2022US000093"}], "primarysource": {"reportercountry": "US", "qualification": "2"}, "sender": {"sendertype": "2", "senderorganization": "FDA-Public Use"}, "receiver": {"receivertype": "6", "receiverorganization": "FDA"}, "patient": {"reaction": [{"reactionmeddraversionpt": "24.1", "reactionmeddrapt": "Myalgia", "reactionoutcome": "6"}, {"reactionmeddraversionpt": "24.1", "reactionmeddrapt": "Muscular weakness", "reactionoutcome": "6"}, {"reactionmeddraversionpt": "24.1", "reactionmeddrapt": "Joint swelling", "reactionoutcome": "6"}, {"reactionmeddraversionpt": "24.1", "reactionmeddrapt": "Dyspnoea", "reactionoutcome": "6"}, {"reactionmeddraversionpt": "24.1", "reactionmeddrapt": "Chest pain", "reactionoutcome": "6"}, {"reactionmeddraversionpt": "24.1", "reactionmeddrapt": "Chest discomfort", "reactionoutcome": "6"}, {"reactionmeddraversionpt": "24.1", "reactionmeddrapt": "Back pain", "reactionoutcome": "6"}, {"reactionmeddraversionpt": "24.1", "reactionmeddrapt": "Overdose", "reactionoutcome": "6"}], "drug": [{"drugcharacterization": "1", "medicinalproduct": "INFLECTRA", "drugbatchnumb": "DK1284", "drugauthorizationnumb": "125544", "drugstructuredosagenumb": "500", "drugstructuredosageunit": "003", "drugdosagetext": "500 MG, EVERY 8 WEEKS", "drugdosageform": "Powder for injection", "drugadministrationroute": "042", "drugindication": "Colitis ulcerative", "actiondrug": "4", "activesubstance": {"activesubstancename": "INFLIXIMAB-DYYB"}}, {"drugcharacterization": "2", "medicinalproduct": "ROSUVASTATIN", "drugbatchnumb": "UNKNOWN", "actiondrug": "5", "drugadditional": "3", "activesubstance": {"activesubstancename": "ROSUVASTATIN"}}, {"drugcharacterization": "2", "medicinalproduct": "NASACORT ALLERGY 24HR", "drugbatchnumb": "UNKNOWN", "actiondrug": "5", "drugadditional": "3", "activesubstance": {"activesubstancename": "TRIAMCINOLONE ACETONIDE"}}, {"drugcharacterization": "2", "medicinalproduct": "OMEPRAZOLE", "drugbatchnumb": "UNKNOWN", "actiondrug": "5", "drugadditional": "3", "activesubstance": {"activesubstancename": "OMEPRAZOLE"}}, {"drugcharacterization": "2", "medicinalproduct": "FISH OIL", "drugbatchnumb": "UNKNOWN", "actiondrug": "5", "drugadditional": "3", "activesubstance": {"activesubstancename": "FISH OIL"}}, {"drugcharacterization": "2", "medicinalproduct": "GINGER", "drugbatchnumb": "Unknown", "actiondrug": "5", "drugadditional": "3", "activesubstance": {"activesubstancename": "GINGER"}}, {"drugcharacterization": "2", "medicinalproduct": "PROBIOTICS [BIFIDOBACTERIUM LONGUM;LACTOBACILLUS ACIDOPHILUS;LACTOBACI", "drugbatchnumb": "UNKNOWN", "actiondrug": "5", "drugadditional": "3"}, {"drugcharacterization": "2", "medicinalproduct": "SUPER LYSINE+", "drugbatchnumb": "UNKNOWN", "actiondrug": "5", "drugadditional": "3"}, {"drugcharacterization": "2", "medicinalproduct": "VITAMIN C ACID [ASCORBIC ACID]", "drugbatchnumb": "UNKNOWN", "actiondrug": "5", "drugadditional": "3"}, {"drugcharacterization": "2", "medicinalproduct": "VITAMIN D3", "drugbatchnumb": "UNKNOWN", "actiondrug": "5", "drugadditional": "3", "activesubstance": {"activesubstancename": "CHOLECALCIFEROL"}}, {"drugcharacterization": "2", "medicinalproduct": "ZINC", "drugbatchnumb": "Unknown", "actiondrug": "5", "drugadditional": "3", "activesubstance": {"activesubstancename": "ZINC"}}, {"drugcharacterization": "2", "medicinalproduct": "DIPHENHYDRAMINE", "drugbatchnumb": "UNKNOWN", "drugdosagetext": "UNK", "actiondrug": "5", "drugadditional": "3", "activesubstance": {"activesubstancename": "DIPHENHYDRAMINE"}}]}}, {"safetyreportversion": "2", "safetyreportid": "20325028", "primarysourcecountry": "US", "occurcountry": "US", "transmissiondateformat": "102", "transmissiondate": "20220423", "reporttype": "1", "serious": "1", "seriousnessdeath": "2", "seriousnesslifethreatening": "2", "seriousnesshospitalization": "2", "seriousnessdisabling": "2", "seriousnesscongenitalanomali": "2", "seriousnessother": "1", "receivedateformat": "102", "receivedate": "20220111", "receiptdateformat": "102", "receiptdate": "20220210", "fulfillexpeditecriteria": "1", "companynumb": "US-CELLTRION INC.-2021US017093", "duplicate": "1", "reportduplicate": [{"duplicatesource": "CELLTRION HEALTHCARE HUNGARY KFT", "duplicatenumb": "US-CELLTRION HEALTHCARE HUNGARY KFT-2021US017093"}, {"duplicatesource": "CELLTRION INC.", "duplicatenumb": "US-CELLTRION INC.-2021US017093"}], "primarysource": {"reportercountry": "US", "qualification": "5"}, "sender": {"sendertype": "2", "senderorganization": "FDA-Public Use"}, "receiver": {"receivertype": "6", "receiverorganization": "FDA"}, "patient": {"reaction": [{"reactionmeddraversionpt": "24.1", "reactionmeddrapt": "Crohn^s disease", "reactionoutcome": "6"}, {"reactionmeddraversionpt": "24.1", "reactionmeddrapt": "Inflammatory bowel disease", "reactionoutcome": "6"}, {"reactionmeddraversionpt": "24.1", "reactionmeddrapt": "Hepatic steatosis", "reactionoutcome": "6"}, {"reactionmeddraversionpt": "24.1", "reactionmeddrapt": "Eye disorder", "reactionoutcome": "6"}, {"reactionmeddraversionpt": "24.1", "reactionmeddrapt": "Off label use", "reactionoutcome": "6"}], "drug": [{"drugcharacterization": "1", "medicinalproduct": "INFLECTRA", "drugbatchnumb": "Unknown", "drugauthorizationnumb": "125544", "drugdosagetext": "UNK", "drugdosageform": "Powder for injection", "drugadministrationroute": "065", "drugindication": "Crohn^s disease", "actiondrug": "5", "drugadditional": "3", "activesubstance": {"activesubstancename": "INFLIXIMAB-DYYB"}}, {"drugcharacterization": "1", "medicinalproduct": "INFLECTRA", "drugbatchnumb": "Unknown", "drugauthorizationnumb": "125544", "drugstructuredosagenumb": "5", "drugstructuredosageunit": "007", "drugdosagetext": "5 MILLIGRAM/KILOGRAM", "drugdosageform": "Powder for injection", "drugadministrationroute": "065", "drugindication": "Inflammatory bowel disease", "actiondrug": "5", "drugadditional": "3", "activesubstance": {"activesubstancename": "INFLIXIMAB-DYYB"}}]}}, {"safetyreportversion": "3", "safetyreportid": "20343326", "primarysourcecountry": "US", "occurcountry": "US", "transmissiondateformat": "102", "transmissiondate": "20220423", "reporttype": "1", "serious": "1", "seriousnessdeath": "1", "seriousnesslifethreatening": "2", "seriousnesshospitalization": "2", "seriousnessdisabling": "2", "seriousnesscongenitalanomali": "2", "seriousnessother": "1", "receivedateformat": "102", "receivedate": "20220117", "receiptdateformat": "102", "receiptdate": "20220310", "fulfillexpeditecriteria": "1", "companynumb": "US-CELLTRION INC.-2022US000392", "duplicate": "1", "reportduplicate": [{"duplicatesource": "CELLTRION INC.", "duplicatenumb": "US-CELLTRION INC.-2022US000392"}, {"duplicatesource": "CELLTRION HEALTHCARE HUNGARY KFT", "duplicatenumb": "US-CELLTRION HEALTHCARE HUNGARY KFT-2022US000392"}], "primarysource": {"reportercountry": "US", "qualification": "3"}, "sender": {"sendertype": "2", "senderorganization": "FDA-Public Use"}, "receiver": {"receivertype": "6", "receiverorganization": "FDA"}, "patient": {"reaction": [{"reactionmeddraversionpt": "24.1", "reactionmeddrapt": "Death", "reactionoutcome": "5"}], "drug": [{"drugcharacterization": "1", "medicinalproduct": "INFLECTRA", "drugbatchnumb": "Unknown", "drugauthorizationnumb": "125544", "drugdosagetext": "UNK", "drugdosageform": "Powder for injection", "drugadministrationroute": "065", "drugindication": "Product used for unknown indication", "actiondrug": "5", "drugadditional": "3", "activesubstance": {"activesubstancename": "INFLIXIMAB-DYYB"}}], "summary": {"narrativeincludeclinical": "CASE EVENT DATE: 20220112"}}}, {"safetyreportversion": "1", "safetyreportid": "20348585", "primarysourcecountry": "US", "occurcountry": "US", "transmissiondateformat": "102", "transmissiondate": "20220423", "reporttype": "1", "serious": "1", "seriousnessdeath": "2", "seriousnesslifethreatening": "2", "seriousnesshospitalization": "2", "seriousnessdisabling": "2", "seriousnesscongenitalanomali": "2", "seriousnessother": "1", "receivedateformat": "102", "receivedate": "20220119", "receiptdateformat": "102", "receiptdate": "20220119", "fulfillexpeditecriteria": "1", "companynumb": "US-CELLTRION INC.-2021US016515", "primarysource": {"reportercountry": "US", "qualification": "5"}, "sender": {"sendertype": "2", "senderorganization": "FDA-Public Use"}, "receiver": {"receivertype": "6", "receiverorganization": "FDA"}, "patient": {"reaction": [{"reactionmeddraversionpt": "24.1", "reactionmeddrapt": "Sympathetic ophthalmia", "reactionoutcome": "6"}, {"reactionmeddraversionpt": "24.1", "reactionmeddrapt": "Ankylosing spondylitis", "reactionoutcome": "6"}, {"reactionmeddraversionpt": "24.1", "reactionmeddrapt": "Keratitis", "reactionoutcome": "6"}, {"reactionmeddraversionpt": "24.1", "reactionmeddrapt": "Off label use", "reactionoutcome": "6"}], "drug": [{"drugcharacterization": "1", "medicinalproduct": "INFLECTRA", "drugbatchnumb": "Unknown", "drugauthorizationnumb": "125544", "drugdosageform": "Powder for injection", "drugadministrationroute": "065", "drugindication": "Ankylosing spondylitis", "actiondrug": "5", "drugadditional": "3", "activesubstance": {"activesubstancename": "INFLIXIMAB-DYYB"}}, {"drugcharacterization": "1", "medicinalproduct": "INFLECTRA", "drugauthorizationnumb": "125544", "drugdosageform": "Powder for injection", "drugindication": "Sympathetic ophthalmia", "actiondrug": "5", "drugadditional": "3", "activesubstance": {"activesubstancename": "INFLIXIMAB-DYYB"}}, {"drugcharacterization": "1", "medicinalproduct": "INFLECTRA", "drugauthorizationnumb": "125544", "drugdosageform": "Powder for injection", "drugindication": "Keratitis", "actiondrug": "5", "drugadditional": "3", "activesubstance": {"activesubstancename": "INFLIXIMAB-DYYB"}}]}}, {"safetyreportversion": "3", "safetyreportid": "20354311", "primarysourcecountry": "US", "occurcountry": "US", "transmissiondateformat": "102", "transmissiondate": "20220423", "reporttype": "1", "serious": "1", "seriousnessdeath": "2", "seriousnesslifethreatening": "2", "seriousnesshospitalization": "2", "seriousnessdisabling": "2", "seriousnesscongenitalanomali": "2", "seriousnessother": "1", "receivedateformat": "102", "receivedate": "20220120", "receiptdateformat": "102", "receiptdate": "20220303", "fulfillexpeditecriteria": "1", "companynumb": "US-CELLTRION INC.-2022US000416", "duplicate": "1", "reportduplicate": [{"duplicatesource": "CELLTRION INC.", "duplicatenumb": "US-CELLTRION INC.-2022US000416"}, {"duplicatesource": "CELLTRION HEALTHCARE HUNGARY KFT", "duplicatenumb": "US-CELLTRION HEALTHCARE HUNGARY KFT-2022US000416"}], "primarysource": {"reportercountry": "US", "qualification": "1"}, "sender": {"sendertype": "2", "senderorganization": "FDA-Public Use"}, "receiver": {"receivertype": "6", "receiverorganization": "FDA"}, "patient": {"reaction": [{"reactionmeddraversionpt": "24.1", "reactionmeddrapt": "Sarcoidosis", "reactionoutcome": "6"}, {"reactionmeddraversionpt": "24.1", "reactionmeddrapt": "Off label use", "reactionoutcome": "6"}], "drug": [{"drugcharacterization": "1", "medicinalproduct": "INFLECTRA", "drugbatchnumb": "UNKNOWN", "drugauthorizationnumb": "125544", "drugdosagetext": "UNK", "drugdosageform": "Powder for injection", "drugadministrationroute": "065", "drugindication": "Sarcoidosis", "actiondrug": "5", "drugadditional": "3", "activesubstance": {"activesubstancename": "INFLIXIMAB-DYYB"}}]}}]}